Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Melissa Ann Burns, M.D.

Concepts (86)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Melissa Burns's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Melissa Burns has written about over time.
Magnetic Resonance Spectroscopy, 3 publications between 2004 and 2005, average publication date March 2005. Prostate, 1 publications between 2005 and 2005, average publication date June 2005. Hedgehog Proteins, 1 publications between 2018 and 2018, average publication date March 2018. Signal Transduction, 1 publications between 2018 and 2018, average publication date March 2018. Wilms Tumor, 1 publications between 2019 and 2019, average publication date August 2019. Cell Transformation, Neoplastic, 2 publications between 2018 and 2021, average publication date August 2019. BRCA2 Protein, 1 publications between 2019 and 2019, average publication date November 2019. Fanconi Anemia Complementation Group D2 Protein, 1 publications between 2019 and 2019, average publication date November 2019. Mutation, 3 publications between 2018 and 2022, average publication date February 2020. Antineoplastic Combined Chemotherapy Protocols, 2 publications between 2019 and 2020, average publication date March 2020. Repressor Proteins, 2 publications between 2019 and 2021, average publication date April 2020. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 6 publications between 2018 and 2023, average publication date August 2020. Clinical Trials, Phase III as Topic, 1 publications between 2020 and 2020, average publication date October 2020. Neoplasm, Residual, 1 publications between 2020 and 2020, average publication date October 2020. Proto-Oncogene Proteins c-ets, 1 publications between 2021 and 2021, average publication date January 2021. Remission Induction, 2 publications between 2020 and 2023, average publication date February 2022. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 2 publications between 2021 and 2023, average publication date April 2022.

To see the data from this visualization as text, click here.
Burns's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (86)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.